127 related articles for article (PubMed ID: 10760100)
1. Lack of evidence of blood pressure-independent protection by renin-angiotensin system blockade after renal ablation.
Bidani AK; Griffin KA; Bakris G; Picken MM
Kidney Int; 2000 Apr; 57(4):1651-61. PubMed ID: 10760100
[TBL] [Abstract][Full Text] [Related]
2. Similar renoprotection after renin-angiotensin-dependent and -independent antihypertensive therapy in 5/6-nephrectomized Ren-2 transgenic rats: are there blood pressure-independent effects?
Kujal P; Chábová VČ; Vernerová Z; Walkowska A; Kompanowska-Jezierska E; Sadowski J; Vaňourková Z; Husková Z; Opočenský M; Skaroupková P; Schejbalová S; Kramer HJ; Rakušan D; Malý J; Netuka I; Vaněčková I; Kopkan L; Cervenka L
Clin Exp Pharmacol Physiol; 2010 Dec; 37(12):1159-69. PubMed ID: 20880190
[TBL] [Abstract][Full Text] [Related]
3. Class differences in the effects of calcium channel blockers in the rat remnant kidney model.
Griffin KA; Picken MM; Bakris GL; Bidani AK
Kidney Int; 1999 May; 55(5):1849-60. PubMed ID: 10231447
[TBL] [Abstract][Full Text] [Related]
4. Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin.
Lebel M; Rodrigue ME; Agharazii M; Larivière R
Am J Hypertens; 2006 Dec; 19(12):1286-92. PubMed ID: 17161776
[TBL] [Abstract][Full Text] [Related]
5. V1/V2 Vasopressin receptor antagonism potentiates the renoprotection of renin-angiotensin system inhibition in rats with renal mass reduction.
Perico N; Zoja C; Corna D; Rottoli D; Gaspari F; Haskell L; Remuzzi G
Kidney Int; 2009 Nov; 76(9):960-7. PubMed ID: 19625993
[TBL] [Abstract][Full Text] [Related]
6. Effects of combined endothelin A receptor and renin-angiotensin system blockade on the course of end-organ damage in 5/6 nephrectomized Ren-2 hypertensive rats.
Vaněčková I; Kujal P; Husková Z; Vaňourková Z; Vernerová Z; Certíková Chábová V; Skaroupková P; Kramer HJ; Tesař V; Červenka L
Kidney Blood Press Res; 2012; 35(5):382-92. PubMed ID: 22487948
[TBL] [Abstract][Full Text] [Related]
7. Protective effects of blocking renin-angiotensin system on the progression of renal injury in glomerulosclerosis.
Ji Z; Huang C; Liang C; Chen B; Chen S; Sun W
Cell Mol Immunol; 2005 Apr; 2(2):150-4. PubMed ID: 16191423
[TBL] [Abstract][Full Text] [Related]
8. Addition of ET(A) receptor blockade increases renoprotection provided by renin-angiotensin system blockade in 5/6 nephrectomized Ren-2 transgenic rats.
Čertíková Chábová V; Vernerová Z; Kujal P; Husková Z; Škaroupková P; Tesař V; Kramer HJ; Kompanowska-Jezierska E; Walkowska A; Sadowski J; Červenka L; Vaněčková I
Life Sci; 2014 Nov; 118(2):297-305. PubMed ID: 24373834
[TBL] [Abstract][Full Text] [Related]
9. Renin-angiotensin system blockade alone or combined with ET
Sedláková L; Čertíková Chábová V; Doleželová Š; Škaroupková P; Kopkan L; Husková Z; Červenková L; Kikerlová S; Vaněčková I; Sadowski J; Kompanowska-Jezierska E; Kujal P; Kramer HJ; Červenka L
Clin Exp Hypertens; 2017; 39(2):183-195. PubMed ID: 28287881
[TBL] [Abstract][Full Text] [Related]
10. Relative antihypertensive and glomeruloprotective efficacies of enalapril and candesartan cilexetil in the remnant kidney model.
Griffin KA; Picken MM; Bakris G; Bidani AK
J Renin Angiotensin Aldosterone Syst; 2001 Mar; 2(1_suppl):S191-S195. PubMed ID: 28095249
[TBL] [Abstract][Full Text] [Related]
11. Differential evolution of blood pressure and renal lesions after RAS blockade in Lyon hypertensive rats.
Bertram D; Blanc-Brunat N; Sassard J; Lo M
Am J Physiol Regul Integr Comp Physiol; 2002 Nov; 283(5):R1041-5. PubMed ID: 12376396
[TBL] [Abstract][Full Text] [Related]
12. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
13. Progression of renal disease: renoprotective specificity of renin-angiotensin system blockade.
Griffin KA; Bidani AK
Clin J Am Soc Nephrol; 2006 Sep; 1(5):1054-65. PubMed ID: 17699327
[TBL] [Abstract][Full Text] [Related]
14. Coinhibition of immune and renin-angiotensin systems reduces the pace of glomerulosclerosis in the rat remnant kidney.
Hamar P; Peti-Peterdi J; Rázga Z; Kovács G; Heemann U; Rosivall L
J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S234-8. PubMed ID: 9892170
[TBL] [Abstract][Full Text] [Related]
15. RAS blockade decreases blood pressure and proteinuria in transgenic mice overexpressing rat angiotensinogen gene in the kidney.
Sachetelli S; Liu Q; Zhang SL; Liu F; Hsieh TJ; Brezniceanu ML; Guo DF; Filep JG; Ingelfinger JR; Sigmund CD; Hamet P; Chan JS
Kidney Int; 2006 Mar; 69(6):1016-23. PubMed ID: 16528251
[TBL] [Abstract][Full Text] [Related]
16. Effects of losartan and benazepril on abnormal circadian blood pressure rhythm and target organ damage in SHRSP.
Shimamura T; Iwasaki T; Hayasaki-Kajiwara Y; Naya N; Nakajima M
Clin Exp Hypertens; 2002 Apr; 24(3):187-205. PubMed ID: 11883791
[TBL] [Abstract][Full Text] [Related]
17. [Contribution of the renin-angiotensin system to the variability of blood pressure in hypertensive rat after blockade of nitric oxide synthesis].
Gouédard O; Gaudet E; Blanc J; Ponchon P; Elghozi JL
Arch Mal Coeur Vaiss; 1996 Aug; 89(8):1013-7. PubMed ID: 8949370
[TBL] [Abstract][Full Text] [Related]
18. Renin angiotensin system blockade ameliorates lead nephropathy.
Ng HY; Tain YL; Lee YT; Hsu CY; Chiou TT; Huang PC; Lee CT
Biochem Biophys Res Commun; 2013 Aug; 438(2):359-63. PubMed ID: 23896603
[TBL] [Abstract][Full Text] [Related]
19. Blood pressure lability and glomerulosclerosis after normotensive 5/6 renal mass reduction in the rat.
Griffin KA; Picken MM; Bidani AK
Kidney Int; 2004 Jan; 65(1):209-18. PubMed ID: 14675052
[TBL] [Abstract][Full Text] [Related]
20. Renoprotection by ACE inhibition or aldosterone blockade is blood pressure-dependent.
Griffin KA; Abu-Amarah I; Picken M; Bidani AK
Hypertension; 2003 Feb; 41(2):201-6. PubMed ID: 12574082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
